Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.
Although optimists once imagined that serious infectious disease threats would by now be conquered, newly emerging (e.g., severe acute respiratory syndrome [SARS]), reemerging (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax bioterrorism) continue to appear throughout the world. Over the past decade, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has resulted in considerable progress. Intramural and extramural investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have contributed substantially to this effort. This overview highlights selected NIAID-sponsored research advances over the past decade, with a focus on progress in combating HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, and potential bioterror agents. Many basic research discoveries have been translated into novel diagnostics, antiviral and antimicrobial compounds, and vaccines, often with extraordinary speed.
Fauci
Anthony S
AS
National Institutes of Health, Bethesda, Maryland 20892, USA.
Touchette
Nancy A
NA
Folkers
Gregory K
GK
D000881:Anthrax / Q000453:epidemiology; D023482:Bioterrorism; D021821:Communicable Diseases, Emerging / Q000453:epidemiology*; D014943:Global Health; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D007251:Influenza, Human / Q000453:epidemiology; D008288:Malaria / Q000453:epidemiology; D009316:National Institutes of Health (U.S.) / Q000191:economics; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology; D014376:Tuberculosis / Q000453:epidemiology; D014481:United States; D014901:West Nile Fever / Q000453:epidemiology